X

Xenon Pharmaceuticals
D

XENE

30.300
USD
-0.71
(-2.29%)
مغلق
حجم التداول
51,811
الربح لكل سهم
-4
العائد الربحي
-
P/E
-9
حجم السوق
2,325,028,050
أصول ذات صلة
A
AKRO
0.035
(0.07%)
50.535 USD
AMGN
AMGN
-2.01
(-0.65%)
306.66 USD
A
ARCT
-0.060
(-0.40%)
14.920 USD
BIIB
BIIB
-1.010
(-0.76%)
131.630 USD
F
FULC
-0.03500
(-0.45%)
7.82000 USD
GOOGL
GOOGL
0.970
(0.50%)
193.170 USD
المزيد
الأخبار المقالات

العنوان: Xenon Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.